EcoDrugPlus

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSDORG00000015110
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSDORG00000015848
Gene Symbol: IL5
4 Cross references
91 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSDORG00000005744
Gene Symbol: IDH1
4 Cross references
232 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSDORG00000014489
Gene Symbol: IDH2
3 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSDORG00000004654
Gene Symbol: KLKB1
4 Cross references
209 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSDORG00000013598
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSDORG00000006837
Gene Symbol: KDR
3 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSDORG00000008541
Gene Symbol: KIF11
3 Cross references
203 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSDORG00000009869
Gene Symbol: KIF5B
4 Cross references
288 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSDORG00000001735
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSDORG00000025200
Gene Symbol: LTB4R
3 Cross references
141 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSDORG00000012290
Gene Symbol: LTB4R2
4 Cross references
238 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).